Healthcare Sales & Marketing Network News: Molecular Profiling

Searching News Database: Molecular Profiling

HSMN NewsFeed - 23 Aug 2024
Caris Life Sciences Announces Appointment of Dave Fredrickson to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 4 Apr 2024
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 25 Apr 2023
Strata Oncology Announces Launch and Medicare Coverage for Strata Select, a First-of-its-kind Immunotherapy Test
Diagnostics Oncology Product Launch Reimbursement

HSMN NewsFeed - 6 Dec 2022
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
Diagnostics Biopharmaceuticals

HSMN NewsFeed - 14 Oct 2022
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 3 Jun 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
Diagnostics Oncology Product Launch

HSMN NewsFeed - 12 Oct 2021
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
Diagnostics Personnel

HSMN NewsFeed - 21 Sep 2021
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
Diagnostics Personnel

HSMN NewsFeed - 28 Jul 2021
Strata Oncology Completes $90 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 27 Oct 2020
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 6 Oct 2020
Caris Life Sciences Appoints Brian Lamon, Ph.D., as Chief Business Officer, Head of BioPharma Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2020
Caris Precision Oncology Alliance Welcomes Penn's Abramson Cancer Center
Diagnostics Oncology

HSMN NewsFeed - 14 Apr 2020
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
Diagnostics Oncology Personnel

HSMN NewsFeed - 31 Mar 2020
Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients
Diagnostics Oncology Product Launch

HSMN NewsFeed - 11 Feb 2020
Caris Life Sciences Appoints New Executive Medical Director
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Diagnostics Oncology Product Launch

HSMN NewsFeed - 3 Jul 2019
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 May 2019
Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI) Transcriptome(TM)
Diagnostics Oncology

HSMN NewsFeed - 3 May 2019
Caris Life Sciences Receives FDA Breakthrough Device Designation for MI Transcriptome(TM) Companion Diagnostic Test
Diagnostics Oncology FDA

HSMN NewsFeed - 1 May 2019
Caris Life Sciences Acquires Pharmatech
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 23 Nov 2018
Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore
Diagnostics Oncology

HSMN NewsFeed - 23 Mar 2018
Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)
Biopharmaceuticals Diagnostics Oncology

HSMN NewsFeed - 27 Nov 2017
Laura Shawver, Ph.D., Appointed CEO of Synthorx
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Sep 2017
Esteemed Researcher and Clinical Oncologist W. Michael Korn, M.D. Joins Caris Life Sciences as Chief Medical Officer
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 4 Apr 2017
Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2017
Ampersand Capital Partners and 1315 Capital to Acquire Genoptix
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 26 Jul 2016
Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 25 May 2016
Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 26 Jan 2016
Inivata Completes £31.5 Million ($45M) Series A Fundraising Round
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 19 Feb 2015
Lifecode Receives CAP Accreditation, Discloses $20.5M Series A-Round Funding Led By Sequoia Capital, the Mayo Clinic and Mayo Ventures
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 5 Aug 2014
Caris Molecular Intelligence(TM) Identifies Key Biomarkers of Clinical Benefit and Resistance to Chemotherapy through Multi-Technology Tumor Profiling
Diagnostics Oncology

HSMN NewsFeed - 2 Dec 2013
Personalized Cancer Therapy, Inc. (Perthera) Launches to Provide New Hope for Fighting Advanced-Stage Cancers
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 18 Jul 2012
NeoGenomics Significantly Expands Molecular Testing Menu and Launches NeoTYPE(TM) Cancer Profile Panels
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 26 Jun 2012
Caris Life Sciences Launches Caris Target Now(TM) Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary
Diagnostics Oncology

HSMN NewsFeed - 7 May 2012
Ruga Corporation Expands Management Team to Advance Its Adaptive Response Therapeutics for Cancer Patients
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 12 Jan 2011
Caris Life Sciences Launches Caris Target Now(TM) Ovarian Profile
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 31 Aug 2010
Dr. Les Paul Joins Caris Life Sciences as Senior Vice President, Medical Affairs
Diagnostics Personnel

HSMN NewsFeed - 19 May 2010
Caris Life Sciences Names Jonathan Knowles, Ph.D., Chief Scientific Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 16 Mar 2010
Caris Life Sciences Announces Two Senior Vice President Appointments
Personalized Medicine Diagnostics Personnel

HSMN NewsFeed - 28 Jan 2010
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2009
Caris Diagnostics Names New Vice Chairman and Board Member, Dr. Jonathan Knowles
Diagnostics Personnel

HSMN NewsFeed - 15 Sep 2009
Caris Diagnostics Appoints Thomas T. Spalding to Senior Vice President, Chief Marketing Officer
Diagnostics Personnel

HSMN NewsFeed - 10 Jul 2009
Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 7 May 2009
Ipsogen Launches a New Test to Guide Hormonotherapy Prescription in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 5 May 2009
Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R)
Diagnostics Oncology

HSMN NewsFeed - 4 May 2009
Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays
Diagnostics Oncology

HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 6 Oct 2008
IPSOGEN expands its U.S. presence through licensing agreement with Quest Diagnostics
Diagnostics Licensing

HSMN NewsFeed - 3 Sep 2008
Ipsogen SA Consolidates its Position in North America and Appoints Susan Hertzberg President, Ipsogen Inc
Diagnostics Personnel

HSMN NewsFeed - 30 Jun 2008
Odanacatib, an Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 May 2008
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Nov 2007
Marketing Application for Vorinostat Filed in Europe for the Treatment of Advanced, Refractory Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 20 Nov 2007
Vertex's Collaborator Merck Suspends Patient Enrollment in Clinical Trials of MK-0457 (VX-680) Pending Full Analysis of Clinical Data
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Sep 2007
Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Sep 2007
The Molecular Profiling Institute Launches Mammostrat(TM) - A Novel, Molecular-Targeted, Prognostic Test for Breast Cancer Patients
Diagnostics Oncology

HSMN NewsFeed - 25 Jul 2007
Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
Biopharmaceuticals Mergers & Acquisitions Oncology

HSMN NewsFeed - 20 Jul 2007
Journal of Clinical Oncology Publishes Data on ZOLINZA(TM) (vorinostat), Merck's Treatment for Advanced Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jun 2007
Dr. Patrice Milos Joins Helicos BioSciences as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2007
Avalon Pharmaceuticals Names Clinical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2006
Avalon Pharmaceuticals Names Todd R. Golub, M.D. as Chairman and Member of Its Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2006
FDA Approves ZOLINZA(TM) (Vorinostat) for the Treatment of Cutaneous Manifestations in Patients with Cutaneous T-Cell Lymphoma Who Have Tried and Failed Other Therapies
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 7 Oct 2006
FDA Approves ZOLINZA(TM) (Vorinostat) for the Treatment of Cutaneous Manifestations in Patients with Cutaneous T-Cell Lymphoma Who Have Tried and Failed Other Therapies
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 10 May 2006
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
Biopharmaceuticals Acquisitions Licensing

Return to NewsFeed

Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 8 additional stories matching:
Molecular Profiling
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.